STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
STAT News · LC · trust 42/100
Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.
Read the original at STAT News →
Open in TruthVane →